The SAFE-BioPharma standard assures the identity trust inherent in implementation of the TransCelerate Shared Investigator Portal, in Merck’s EngageZone portal, and in other industry collaboration portals. Digital signature applications certified compliant with the SAFE-BioPharma standard meet global regulatory and legal requirements. The association's members include most of the world’s major global biopharmaceutical companies. Ms. Shields Uehling has more than 20 years of international trade and biopharmaceutical industry experience.

His expertise includes creating the architectures for Identity and Access Management (IAM) and Enterprise Knowledge Management (EKM) solutions that support Merck's External Partner Program (EPP) and clinical trials initiatives. Mr. Porter has also provided architectural alignment and guidance for overall Merck Research Labs (MRL) operations, including worldwide licensing.